China's State Development and Investment Corporation has picked up an 18.6% stake in Sihuan Pharmaceutical’s drug development spinoff, Xuanzhu Biopharmaceutical.

Lilly Asia Ventures was among the new investors in a series C round for autoimmune and inflammatory disease drug developer Connect Biopharma.

TearClear has raised $34.8m to date to fund an anti-preservative eye drop technology invented at University of Florida.

The predictive logistics platform developer has raised a further $13m, adding to $24.5m raised from investors including M12 and Honeywell Ventures in April.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CapitalG, which joined Dataiku’s shareholders through a secondary transaction last year, has now made its first primary investment in the data management software provider.

Gigafund led a series C round for the GV and Stripe-backed online coding school to increase its overall funding to approximately $122m.

GlaxoSmithKline’s Action Potential Venture Capital fund led a series B-plus round that included TDK Ventures, Intel Capital and Applied Ventures.

Takasago Thermal Engineering and Mitsui Sumitomo Insurance made strategic investments in the moon exploration business, which has now raised $125m in total.

Boston Children’s Hospital, Blue Cross Blue Shield of Massachusetts and Blue Shield of California have all invested in the children's behavioural healthcare provider.